During the treatment of ALL with l-asparaginase, all the circulating asparagine in the body of the patient get hydrolysed to aspartic acid and ammonia preventing the absorption of asparagine by tumour cells thereby depriving the tumour cells of their extracellular source of l-asparagine (Broome 1961). This evidence concerns the gene ASPG and neoplasm.